Trump highlights the success of his digital platform in lowering prescription drug costs

Former president Donald Trump used his speech about Estado of União this Tuesday, in February 2026, to highlight what he called significant progress in reducing drug prices. Durante the speech, he proudly presented the TrumpRx.gov website and his “most favored nation” policy as evidence that he had achieved a goal that, according to him, his predecessors had failed to achieve.
Trump claimed to have reversed the scenario of uncontrolled increase in the prices of controlled medicines, transforming what was previously the most expensive market in the world into one of the most accessible. Esta declaração sublinha a importância que sua administração atribui à acessibilidade dos cuidados de saúde para a população.
He highlighted the drastic price difference, citing reductions of up to 600% or more, now available through the new online platform. The initiative seeks to offer a direct solution to consumers who face high daily medication costs.
Initiative details
Launched at the beginning of the month of the speech, TrumpRx.gov operates as a digital coupon portal for a wide range of medications. Usuários can print or download discounts directly to their cell phones and use them at partner pharmacies, simplifying the process of accessing lower prices and essential treatments.
Individual success and scope
To illustrate the impact of the platform, Trump mentioned Catherine Rayner, a military wife and early TrumpRx user. Ela was able to purchase an essential fertility treatment medication that previously cost $4,000 for less than $500, a testament to the savings the program can generate for specific patients.
Most favored nation policy
The “most favored nation policy” (MFN), defended by Trump, seeks to equate drug prices in Estados Unidos with those practiced in other developed countries. The logic behind this measure is that pharmaceutical companies should offer the same low prices to the US that they offer to nations with more centralized healthcare systems, aiming for market equity.
Market analysis and alternatives
However, market analysts note that many of the drugs included on TrumpRx.gov already have generic versions available at considerably lower prices. Além Furthermore, platforms like GoodRx offer similar coupons and discounts, raising questions about the real innovation and exclusivity of the new initiative in the current scenario of the pharmaceutical market.
Legislative proposals and challenges
The former president reiterated his request to Congresso for the MFN policy to be converted into law. Essa legislative action would make the measure permanent, solidifying the basis for future price negotiations and ensuring the continuity of the long-term cost containment strategy. The discussion about the accessibility of medicines in the Estados Unidos is complex and involves several actors, from manufacturers to insurers and patients, all with different interests and challenges.
Future perspectives
Despite criticism, the Trump initiative highlights the urgency of finding solutions to the rising cost of healthcare. Seja through coupons, negotiation policies or other approaches, the ultimate goal is to ease the financial burden on patients.







